• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Baudax Bio, Inc.

    Baudax Bio Reports First Quarter Financial Results and Provides Business Update
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Baudax Bio to Present at the Sidoti Virtual Investor Conference
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Baudax Bio Announces Closing of $4 Million Public Offering
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Baudax Bio Announces Pricing of $4 Million Public Offering
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Baudax Bio to Host Key Opinion Leader Webinar to Discuss Results of Phase 2 BX1000 Trial
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Baudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Baudax Bio Announces Closing of $5 Million Public Offering
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Baudax Bio Announces Pricing of $5 Million Public Offering
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Baudax Bio Announces 1-for-40 Reverse Stock Split
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Baudax Bio Reports Third Quarter 2022 Financial Results and Business Highlights
    From Baudax Bio, Inc.
    Via GlobeNewswire
    Tickers BXRX
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.